88IV - Public company info - Giant Biogene Holding Co. Ltd

Input the stock code or the company name

Giant Biogene Holding Co. Ltd, 02367.HK - Cash Flow	2021-12	2020-12	2019-12
Net Cash Flow from Operating Activities	910,658	955,258	715,962
Net Cash Flow from Return on Investments & Servicing of Finance	-2,540,592	8,377	16,181
Interest Received	9,408	9,882	16,181
Interest Paid	0	0	0
Dividend Received	0	0	0
Dividend Paid	-2,550,000	-1,505	0
Others	0	0	0
Taxes (Paid) / Refunded	-218,257	-121,134	-59,505
Net Cash Flow from Investing Activities	1,553,858	-531,001	-606,027
Additions to Fixed Assets	-111,061	-75,506	-114,725
Disposal of Fixed Assets	16,528	0	0
Increase in Investments	-3,925,113	-5,084,378	-1,491,184
Decrease in Investments	5,372,324	4,397,435	984,204
Net Cash Flow with Related Parties	7,025,801	-16,018	-2,164
Others	-6,824,621	247,466	17,842
Net Cash Flow before Financing Activities	-294,333	311,500	66,611
Net Cash Flow from Financing Activities	7,025,544	-16,018	-2,164
New Loans	0	0	0
Loans Repayment	0	0	0
Fixed Income/Debt Instruments	0	0	0
Repayment of Fixed Income/Debt Instruments	0	0	0
Equity Financing	57	0	0
Net Cash Flow with Related Parties	7,025,801	-16,018	-2,164
Others	-314	0	0
Increase(Decrease) in Cash & Cash Equivalents	6,731,211	295,482	64,447
Cash & Cash Equivalents at Beginning of Year	367,805	72,323	7,876
Net Cash Flow due to Change in Exchange Rate/Others	3,984	0	0
Cash & Cash Equivalents at End of Year	7,103,000	367,805	72,323
Currency	Renminbi	Renminbi	Renminbi
Unit
Auditor's Opinion	0	0	0

Notes:1–Unqualified; 2–Unqualified ( not qualified in respect of fundamental uncertainly because of proper disclosure); 3–Qualified

Public company info - Giant Biogene Holding Co. Ltd , 02367.HK